Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1990 1
1991 4
1992 2
1993 4
1994 3
1995 9
1996 7
1997 6
1998 8
1999 10
2000 7
2001 21
2002 17
2003 13
2004 17
2005 23
2006 22
2007 21
2008 19
2009 16
2010 35
2011 32
2012 32
2013 37
2014 57
2015 72
2016 64
2017 68
2018 58
2019 55
2020 28
Text availability
Article attribute
Article type
Publication date

Search Results

681 results
Results by year
Filters applied: . Clear all
Page 1
Depression, fatigue and neurocognitive deficits in chronic hepatitis C.
Yeoh SW, Holmes ACN, Saling MM, Everall IP, Nicoll AJ. Yeoh SW, et al. Hepatol Int. 2018 Jul;12(4):294-304. doi: 10.1007/s12072-018-9879-5. Epub 2018 Jun 21. Hepatol Int. 2018. PMID: 29931590 Review.
Patients with chronic hepatitis C virus (HCV) infection experience a range of symptoms including depression, fatigue and neurocognitive deficits, impairing quality of life. ...However, even patients at an early stage of HCV infection, with minimal hepa …
Patients with chronic hepatitis C virus (HCV) infection experience a range of symptoms including depression, fatigue
Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection.
Golabi P, Sayiner M, Bush H, Gerber LH, Younossi ZM. Golabi P, et al. Clin Liver Dis. 2017 Aug;21(3):565-578. doi: 10.1016/j.cld.2017.03.011. Epub 2017 Apr 26. Clin Liver Dis. 2017. PMID: 28689594 Review.
Fatigue is a common symptom. Diagnosis is difficult. Fatigue is often a complex symptom. In the recent years, fatigue has gained considerable amount of attention. ...Although fatigue has many strong relations with depression and sleep disorders, it is
Fatigue is a common symptom. Diagnosis is difficult. Fatigue is often a complex symptom. In the recent years, fatigue h
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.
Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, Zampino R, Rinaldi L, Sellitto A, Giordano M, Marrone A. Adinolfi LE, et al. World J Gastroenterol. 2015 Feb 28;21(8):2269-80. doi: 10.3748/wjg.v21.i8.2269. World J Gastroenterol. 2015. PMID: 25741133 Free PMC article. Review.
Hepatitis C virus (HCV) infection is considered a systemic disease because of involvement of other organs and tissues concomitantly with liver disease. Among the extrahepatic manifestations, neuropsychiatric disorders have been reported in up to 50% of chronic
Hepatitis C virus (HCV) infection is considered a systemic disease because of involvement of other organs and tissues concomit
Fatigue in chronic hepatitis C infection: Understanding patients' experience from a cognitive-behavioural perspective.
Zalai D, Carney CE, Sherman M, Shapiro CM, McShane K. Zalai D, et al. Br J Health Psychol. 2016 Feb;21(1):157-72. doi: 10.1111/bjhp.12155. Epub 2015 Aug 6. Br J Health Psychol. 2016. PMID: 26250404
OBJECTIVES: Fatigue is a leading concern of patients with chronic hepatitis C virus (HCV) infection. Despite its clinical significance, fatigue in HCV is poorly understood and therefore invariably under-treated. ...Fatigue is a key patien …
OBJECTIVES: Fatigue is a leading concern of patients with chronic hepatitis C virus (HCV) infection. Despite its …
Extrahepatic morbidity and mortality of chronic hepatitis C.
Negro F, Forton D, Craxì A, Sulkowski MS, Feld JJ, Manns MP. Negro F, et al. Gastroenterology. 2015 Nov;149(6):1345-60. doi: 10.1053/j.gastro.2015.08.035. Epub 2015 Aug 28. Gastroenterology. 2015. PMID: 26319013 Review.
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its sequelae, ranging from cutaneous and visceral vasculitis to glomerulonephritis and B-cell non-Hodgki
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may
The importance of fatigue cognitions in chronic hepatitis C infection.
Zalai D, Sherman M, McShane K, Shapiro CM, Carney CE. Zalai D, et al. J Psychosom Res. 2015 Feb;78(2):193-8. doi: 10.1016/j.jpsychores.2014.11.011. Epub 2014 Nov 18. J Psychosom Res. 2015. PMID: 25433976
Chronic Hepatitis C virus (HCV) infection is a source of significant public health burden worldwide. Fatigue is a cardinal patient reported consequence of the disease. ...Integrating the findings into existing treatment strategies could improve patient
Chronic Hepatitis C virus (HCV) infection is a source of significant public health burden worldwide. Fatigue is
Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome.
Russell A, Hepgul N, Nikkheslat N, Borsini A, Zajkowska Z, Moll N, Forton D, Agarwal K, Chalder T, Mondelli V, Hotopf M, Cleare A, Murphy G, Foster G, Wong T, Schütze GA, Schwarz MJ, Harrison N, Zunszain PA, Pariante CM. Russell A, et al. Psychoneuroendocrinology. 2019 Feb;100:276-285. doi: 10.1016/j.psyneuen.2018.11.032. Epub 2018 Dec 17. Psychoneuroendocrinology. 2019. PMID: 30567628 Free PMC article.
This study presents interferon-alpha (IFN-α)-induced persistent fatigue as a model of CFS. IFN-α, which is used in the treatment of chronic Hepatitis C Virus (HCV) infection, induces a persistent fatigue in some individuals, which does not abate …
This study presents interferon-alpha (IFN-α)-induced persistent fatigue as a model of CFS. IFN-α, which is used in the treatment of …
Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C.
Childs-Kean LM, Brumwell NA, Lodl EF. Childs-Kean LM, et al. Infect Drug Resist. 2019 Jul 23;12:2259-2268. doi: 10.2147/IDR.S171338. eCollection 2019. Infect Drug Resist. 2019. PMID: 31413603 Free PMC article. Review.
The treatment of chronic hepatitis C has been revolutionized with the introduction of direct-acting antivirals (DAAs). However, some patients are not cured with first-line treatment. Sofosbuvir/velpatasvir/voxilaprevir is a fixed-dose combination of a polymer …
The treatment of chronic hepatitis C has been revolutionized with the introduction of direct-acting antivirals (DAAs). …
Sofosbuvir-velpatasvir: A single-tablet treatment for hepatitis C infection of all genotypes.
Miller MM. Miller MM. Am J Health Syst Pharm. 2017 Jul 15;74(14):1045-1052. doi: 10.2146/ajhp60632. Am J Health Syst Pharm. 2017. PMID: 28687550 Review.
PURPOSE: The pharmacology, pharmacokinetics, interaction potential, efficacy, and safety of the newest direct-acting antiviral (DAA) medication for the treatment of chronic hepatitis C are reviewed. SUMMARY: Nonstructural proteins 5A (NS5A) and 5B (NS5B) are …
PURPOSE: The pharmacology, pharmacokinetics, interaction potential, efficacy, and safety of the newest direct-acting antiviral (DAA) medicat …
Systematic review with meta-analysis: neuroimaging in hepatitis C chronic infection.
Oriolo G, Egmond E, Mariño Z, Cavero M, Navines R, Zamarrenho L, Solà R, Pujol J, Bargallo N, Forns X, Martin-Santos R. Oriolo G, et al. Aliment Pharmacol Ther. 2018 May;47(9):1238-1252. doi: 10.1111/apt.14594. Epub 2018 Mar 14. Aliment Pharmacol Ther. 2018. PMID: 29536563 Free article.
BACKGROUND: Chronic hepatitis C is considered a systemic disease because of extra-hepatic manifestations. Neuroimaging has been employed in hepatitis C virus-infected patients to find in vivo evidence of central nervous system alterations. ...CO …
BACKGROUND: Chronic hepatitis C is considered a systemic disease because of extra-hepatic manifestations. Neuroimaging …
681 results
Jump to page
Feedback